A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Karyopharm Therapeutics Inc
Princess Maxima Center for Pediatric Oncology
Fondazione Italiana Linfomi - ETS
Sorrento Therapeutics, Inc.
SecuraBio
Incyte Corporation
Novartis
Rutgers, The State University of New Jersey
University College, London
Children's Hospital Medical Center, Cincinnati
University of Michigan Rogel Cancer Center
Royal Marsden NHS Foundation Trust
CTI BioPharma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jazz Pharmaceuticals
Yale University
Verastem, Inc.
M.D. Anderson Cancer Center
AstraZeneca
University of Alabama at Birmingham
Molecular Templates, Inc.
M.D. Anderson Cancer Center
AbbVie
Children's Oncology Group
AbbVie
Mayo Clinic
La Jolla Pharmaceutical Company
Columbia University
M.D. Anderson Cancer Center
Enzon Pharmaceuticals, Inc.
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nevada Cancer Institute